BW
BAM Wealth Management, LLC
13F filer · CIK 0002093649Reported Jul 14, 2026
Net buyer this quarter
13F portfolio value$160MU.S. long equity reported on 13F
Positions8515 new · 14 closed
Net flow last quarter+$641KBuys minus sells
Top 10 positions weight16.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 14, 202685 positions | |||||
| $4.83M | 3.02% | 0.00% | +1.3% | Q3 2025 | |
| $3.87M | 2.42% | 0.00% | +11.1% | Q3 2025 | |
| $3.29M | 2.06% | 0.00% | +45.1% | Q3 2025 | |
| $3.17M | 1.98% | 0.00% | +7.0% | Q3 2025 | |
| $2.56M | 1.60% | 0.00% | +1.9% | Q3 2025 | |
| $2.38M | 1.49% | 0.00% | +37.9% | Q3 2025 | |
| $1.94M | 1.21% | Not reported | +27.0% | Q3 2025 | |
| $1.82M | 1.14% | 0.00% | -3.5% | Q3 2025 | |
| $1.67M | 1.04% | Not reported | +38.9% | Q3 2025 | |
| PBPMBSPuramed Bioscience Inc. | $1.57M | 0.98% | 0.02% | +5.1% | Q3 2025 |
| $1.47M | 0.92% | 0.00% | +37.9% | Q3 2025 | |
| $1.24M | 0.78% | 0.00% | +55.9% | Q3 2025 | |
| $1.2M | 0.75% | Not reported | +227.3% | Q1 2026 | |
| $1.12M | 0.70% | 0.00% | Not reported | Q3 2025 | |
| $1.08M | 0.68% | 0.00% | -42.9% | Q3 2025 | |
| $1.03M | 0.65% | 0.00% | -7.5% | Q3 2025 | |
| $926K | 0.58% | 0.00% | +241.4% | Q3 2025 | |
| $921K | 0.58% | 0.00% | -1.0% | Q3 2025 | |
| $864K | 0.54% | 0.00% | -56.1% | Q3 2025 | |
| $822K | 0.51% | 0.00% | New | Q2 2026 | |
| $807K | 0.51% | 0.00% | -23.1% | Q1 2026 | |
| $780K | 0.49% | 0.00% | +18.7% | Q3 2025 | |
| $759K | 0.47% | 0.00% | New | Q2 2026 | |
| $758K | 0.47% | 0.00% | -24.2% | Q4 2025 | |
| $756K | 0.47% | 0.00% | +20.4% | Q3 2025 | |
| $745K | 0.47% | 0.00% | -18.9% | Q1 2026 | |
| $744K | 0.47% | 0.00% | -22.3% | Q3 2025 | |
| $739K | 0.46% | 0.00% | New | Q2 2026 | |
| $724K | 0.45% | 0.00% | -10.7% | Q3 2025 | |
| $682K | 0.43% | 0.00% | +7.1% | Q1 2026 | |
| $675K | 0.42% | 0.00% | +15.0% | Q3 2025 | |
| $669K | 0.42% | 0.00% | -3.9% | Q3 2025 | |
| $650K | 0.41% | 0.00% | +0.8% | Q3 2025 | |
| $637K | 0.40% | Not reported | +45.4% | Q4 2025 | |
| $614K | 0.38% | 0.00% | New | Q2 2026 | |
| $613K | 0.38% | 0.00% | -8.1% | Q3 2025 | |
| $529K | 0.33% | 0.00% | -39.0% | Q3 2025 | |
| $516K | 0.32% | 0.00% | -43.2% | Q4 2025 | |
| $483K | 0.30% | 0.01% | +37.7% | Q1 2026 | |
| $480K | 0.30% | 0.00% | +28.2% | Q4 2025 | |
| $471K | 0.29% | 0.00% | +23.1% | Q3 2025 | |
| $454K | 0.28% | 0.01% | +56.6% | Q3 2025 | |
| $453K | 0.28% | 0.00% | +73.1% | Q3 2025 | |
| $449K | 0.28% | 0.00% | +8.7% | Q3 2025 | |
| $449K | 0.28% | 0.03% | +42.3% | Q1 2026 | |
| $445K | 0.28% | Not reported | +23.7% | Q3 2025 | |
| $438K | 0.27% | 0.00% | +8.9% | Q3 2025 | |
| $422K | 0.26% | 0.00% | +42.7% | Q4 2025 | |
| $420K | 0.26% | 0.01% | +23.2% | Q1 2026 | |
| $418K | 0.26% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported Apr 17, 202684 positions | |||||
| $4.49M | 3.36% | 0.47% | New | Q1 2026 | |
| $4.18M | 3.12% | 0.00% | +1.1% | Q3 2025 | |
| $3.03M | 2.27% | 0.00% | -2.5% | Q3 2025 | |
| $2.94M | 2.20% | 0.00% | +4.0% | Q3 2025 | |
| $2.16M | 1.61% | 0.00% | +57.4% | Q3 2025 | |
| $2.06M | 1.54% | 0.00% | +2.3% | Q3 2025 | |
| $1.83M | 1.37% | 0.00% | -9.1% | Q3 2025 | |
| $1.51M | 1.13% | 0.00% | -5.2% | Q3 2025 | |
| PBPMBSPuramed Bioscience Inc. | $1.5M | 1.12% | 0.02% | +10.7% | Q3 2025 |
| $1.44M | 1.08% | 0.00% | +29.5% | Q3 2025 | |
| $1.28M | 0.96% | Not reported | -0.7% | Q3 2025 | |
| $1.22M | 0.91% | Not reported | +3.4% | Q3 2025 | |
| $982K | 0.73% | 0.00% | New | Q1 2026 | |
| $941K | 0.70% | 0.00% | -8.9% | Q3 2025 | |
| $896K | 0.67% | 0.00% | -28.1% | Q3 2025 | |
| $888K | 0.66% | 0.00% | -8.9% | Q3 2025 | |
| $852K | 0.64% | 0.00% | +6.4% | Q3 2025 | |
| $799K | 0.60% | 0.00% | -22.1% | Q3 2025 | |
| $798K | 0.60% | 0.00% | -12.7% | Q3 2025 | |
| $789K | 0.59% | 0.00% | -10.1% | Q3 2025 | |
| $779K | 0.58% | 0.00% | New | Q1 2026 | |
| $770K | 0.58% | 0.00% | -6.3% | Q4 2025 | |
| $727K | 0.54% | 0.00% | -11.3% | Q3 2025 | |
| $708K | 0.53% | 0.00% | -12.2% | Q3 2025 | |
| $706K | 0.53% | 0.00% | -8.8% | Q3 2025 | |
| $673K | 0.50% | 0.00% | New | Q1 2026 | |
| $666K | 0.50% | 0.00% | -9.9% | Q3 2025 | |
| $654K | 0.49% | 0.00% | -10.2% | Q3 2025 | |
| $653K | 0.49% | 0.00% | -8.8% | Q3 2025 | |
| $642K | 0.48% | 0.00% | -5.3% | Q3 2025 | |
| $635K | 0.47% | 0.00% | +0.2% | Q3 2025 | |
| $555K | 0.42% | 0.00% | +0.5% | Q3 2025 | |
| $538K | 0.40% | 0.00% | -19.9% | Q3 2025 | |
| $442K | 0.33% | Not reported | +109.2% | Q4 2025 | |
| $424K | 0.32% | 0.01% | +11.3% | Q4 2025 | |
| $414K | 0.31% | Not reported | +170.5% | Q3 2025 | |
| $394K | 0.29% | 0.00% | New | Q1 2026 | |
| $382K | 0.29% | Not reported | -33.0% | Q3 2025 | |
| $378K | 0.28% | 0.00% | +6.3% | Q3 2025 | |
| $361K | 0.27% | 0.00% | -31.3% | Q4 2025 | |
| $361K | 0.27% | Not reported | +10.3% | Q3 2025 | |
| $351K | 0.26% | 0.00% | -5.7% | Q3 2025 | |
| $326K | 0.24% | 0.00% | -15.1% | Q3 2025 | |
| $325K | 0.24% | 0.01% | New | Q1 2026 | |
| $323K | 0.24% | 0.00% | -4.8% | Q3 2025 | |
| $319K | 0.24% | 11806.00% | +18.6% | Q3 2025 | |
| $316K | 0.24% | 0.00% | -14.4% | Q3 2025 | |
| $315K | 0.24% | 0.02% | New | Q1 2026 | |
| $314K | 0.23% | 0.00% | +1.8% | Q3 2025 | |
| $308K | 0.23% | Not reported | -14.2% | Q3 2025 | |
| Q4 2025Reported Jan 20, 202687 positions | |||||
| $4.43M | 3.20% | 0.00% | -1.3% | Q3 2025 | |
| $3.7M | 2.67% | 0.00% | +0.2% | Q3 2025 | |
| $3.33M | 2.41% | 0.00% | +17.1% | Q3 2025 | |
| $2.25M | 1.63% | 0.00% | -10.4% | Q3 2025 | |
| $2.19M | 1.58% | 0.00% | -0.5% | Q3 2025 | |
| $1.76M | 1.27% | 0.00% | +6.1% | Q3 2025 | |
| $1.38M | 0.99% | Not reported | -18.2% | Q3 2025 | |
| $1.36M | 0.98% | Not reported | +6.5% | Q3 2025 | |
| PBPMBSPuramed Bioscience Inc. | $1.36M | 0.98% | 0.01% | +31.0% | Q3 2025 |
| $1.3M | 0.94% | 0.00% | -14.9% | Q3 2025 | |
| $1.23M | 0.89% | 0.00% | +0.4% | Q3 2025 | |
| $1.23M | 0.89% | 0.00% | -5.3% | Q3 2025 | |
| $1.2M | 0.87% | 0.00% | -4.0% | Q3 2025 | |
| $1.1M | 0.79% | 0.00% | +309.1% | Q3 2025 | |
| $1.09M | 0.79% | 0.00% | +33.5% | Q3 2025 | |
| $1M | 0.72% | 0.00% | -7.5% | Q3 2025 | |
| $936K | 0.68% | 0.00% | -26.4% | Q3 2025 | |
| $914K | 0.66% | 0.00% | -8.1% | Q3 2025 | |
| $914K | 0.66% | 0.00% | +31.9% | Q3 2025 | |
| $866K | 0.63% | 0.00% | -7.2% | Q3 2025 | |
| $865K | 0.63% | 0.00% | -7.4% | Q3 2025 | |
| $844K | 0.61% | 0.00% | -21.6% | Q3 2025 | |
| $840K | 0.61% | 0.00% | -22.9% | Q3 2025 | |
| $833K | 0.60% | 0.00% | -6.1% | Q3 2025 | |
| $828K | 0.60% | 0.00% | -5.0% | Q3 2025 | |
| $810K | 0.59% | 0.00% | -6.3% | Q3 2025 | |
| $788K | 0.57% | 0.00% | New | Q4 2025 | |
| $738K | 0.53% | 0.00% | +30.8% | Q3 2025 | |
| $722K | 0.52% | 0.00% | -7.0% | Q3 2025 | |
| $668K | 0.48% | 0.00% | +6.1% | Q3 2025 | |
| $660K | 0.48% | 0.00% | -8.1% | Q3 2025 | |
| $629K | 0.45% | 0.00% | -0.6% | Q3 2025 | |
| $587K | 0.42% | 0.00% | +33.0% | Q3 2025 | |
| $572K | 0.41% | Not reported | -8.5% | Q3 2025 | |
| $552K | 0.40% | 0.00% | -0.2% | Q3 2025 | |
| $445K | 0.32% | 0.00% | New | Q4 2025 | |
| $433K | 0.31% | 0.00% | -15.3% | Q3 2025 | |
| $432K | 0.31% | 0.00% | New | Q4 2025 | |
| $420K | 0.30% | 0.00% | +65.2% | Q3 2025 | |
| $414K | 0.30% | 0.00% | +11.5% | Q3 2025 | |
| $394K | 0.28% | 0.00% | -0.9% | Q3 2025 | |
| $392K | 0.28% | 0.00% | +14.7% | Q3 2025 | |
| $369K | 0.27% | Not reported | +6.1% | Q3 2025 | |
| $367K | 0.27% | 0.00% | +21.8% | Q3 2025 | |
| $351K | 0.25% | Not reported | +4.8% | Q3 2025 | |
| $349K | 0.25% | 0.00% | New | Q4 2025 | |
| $347K | 0.25% | 0.00% | +3.9% | Q3 2025 | |
| $343K | 0.25% | 0.00% | -6.3% | Q3 2025 | |
| $342K | 0.25% | 0.00% | +20.0% | Q3 2025 | |
| $342K | 0.25% | 0.00% | -7.0% | Q3 2025 | |
| Q3 2025Reported Oct 31, 202578 positions | |||||
| $4.2M | 3.25% | 0.00% | New | Q3 2025 | |
| $3.95M | 3.06% | 0.00% | New | Q3 2025 | |
| $2.84M | 2.20% | 0.00% | New | Q3 2025 | |
| $2.4M | 1.86% | 0.00% | New | Q3 2025 | |
| $1.71M | 1.32% | 0.00% | New | Q3 2025 | |
| $1.64M | 1.27% | Not reported | New | Q3 2025 | |
| $1.58M | 1.22% | 0.00% | New | Q3 2025 | |
| $1.42M | 1.10% | Not reported | New | Q3 2025 | |
| $1.34M | 1.03% | 0.00% | New | Q3 2025 | |
| $1.21M | 0.94% | 0.00% | New | Q3 2025 | |
| $1.13M | 0.88% | 0.00% | New | Q3 2025 | |
| $1.09M | 0.84% | 0.00% | New | Q3 2025 | |
| $1.08M | 0.84% | 0.00% | New | Q3 2025 | |
| $1.06M | 0.82% | 0.00% | New | Q3 2025 | |
| $1.04M | 0.81% | 0.00% | New | Q3 2025 | |
| PBPMBSPuramed Bioscience Inc. | $1.03M | 0.80% | 0.01% | New | Q3 2025 |
| $1.01M | 0.79% | 0.00% | New | Q3 2025 | |
| $943K | 0.73% | 0.00% | New | Q3 2025 | |
| $931K | 0.72% | 0.00% | New | Q3 2025 | |
| $901K | 0.70% | 0.00% | New | Q3 2025 | |
| $892K | 0.69% | 0.00% | New | Q3 2025 | |
| $879K | 0.68% | 0.00% | New | Q3 2025 | |
| $871K | 0.67% | 0.00% | New | Q3 2025 | |
| $833K | 0.65% | 0.00% | New | Q3 2025 | |
| $767K | 0.59% | 0.00% | New | Q3 2025 | |
| $751K | 0.58% | 0.00% | New | Q3 2025 | |
| $743K | 0.58% | 0.01% | New | Q3 2025 | |
| $704K | 0.55% | 0.00% | New | Q3 2025 | |
| $678K | 0.53% | 0.00% | New | Q3 2025 | |
| $638K | 0.49% | 0.00% | New | Q3 2025 | |
| $626K | 0.49% | Not reported | New | Q3 2025 | |
| $623K | 0.48% | 0.00% | New | Q3 2025 | |
| $622K | 0.48% | 0.00% | New | Q3 2025 | |
| $611K | 0.47% | 0.00% | New | Q3 2025 | |
| $545K | 0.42% | 0.00% | New | Q3 2025 | |
| $505K | 0.39% | 0.00% | New | Q3 2025 | |
| $427K | 0.33% | 0.00% | New | Q3 2025 | |
| $397K | 0.31% | 0.00% | New | Q3 2025 | |
| $396K | 0.31% | Not reported | New | Q3 2025 | |
| $387K | 0.30% | 0.00% | New | Q3 2025 | |
| $357K | 0.28% | 0.00% | New | Q3 2025 | |
| $353K | 0.27% | 0.00% | New | Q3 2025 | |
| $351K | 0.27% | 0.00% | New | Q3 2025 | |
| $346K | 0.27% | Not reported | New | Q3 2025 | |
| $342K | 0.27% | 0.00% | New | Q3 2025 | |
| $340K | 0.26% | 0.00% | New | Q3 2025 | |
| $335K | 0.26% | 0.00% | New | Q3 2025 | |
| $329K | 0.26% | 0.00% | New | Q3 2025 | |
| $322K | 0.25% | 0.00% | New | Q3 2025 | |
| $321K | 0.25% | Not reported | New | Q3 2025 | |
Premium opens every quarter this fund has filed